Venture Director

There are venture directors.., and then there are altVenture Directors

 

Most EMMA and/or early companies need mentoring and support in governance ways, but even more so for risk mitigation, business & corporate development, or hiring & firing… 

Please connect for Emerging Market Venture Capital Advisory as in independent non-exec hand-holding, industry & financial expertise, etc.

 

Corona Update

In line with ‘the new normal’ – altVENTURE @ 2EMMA caters for outsourced / subcontracted / remote / desktop deal or project execution for either side of the investment table:

  • research, analysis & evaluation
  • BP, strategy & pitch development
  • financial modelling & valuation
  • structuring & negotiation
  • due diligence & closing documentation

Contact Us

 

Theme Related Tracker

    Feed has no items.
  • Inspired by animal immunity, Germany’s Kupando raises €10 million for cancer therapy
    on March 18, 2026

    Schönefeld-based Kupando, a biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity and induces trained immunity for use in oncology and infectious diseases, has secured an additional €10 million in Series A financing – bringing their total Series A to €23 million. The investment was again led by Remiges Ventures, co-led by LifeCare The post Inspired by animal immunity, Germany’s Kupando raises €10 million for cancer therapy appeared first on EU-Startups.

  • Hadi Moussa, CEO of the HR unicorn Oyster, will join the EU-Startups Summit 2026!
    on March 18, 2026

    We are excited to announce that Hadi Moussa, CEO of Oyster, will take the main stage at the EU-Startups Summit 2026 on May 7-8 in sunny Malta. Hadi brings extensive experience in scaling high-growth technology companies through critical expansion phases. Over the course of his career, he has held leadership roles at companies such as The post Hadi Moussa, CEO of the HR unicorn Oyster, will join the EU-Startups Summit 2026! appeared first on EU-Startups.

  • Austria’s sequestra secures €3 million Seed to scale its CO2 mineralisation technology for industrial use
    on March 18, 2026

    sequestra, a Vienna-based ClimateTech startup, has secured a €3 million Seed investment to accelerate the industrial scale-up of its CO2 mineralisation technology. The round was led by VSE Beteiligungs-GmbH, supported by the Dr Rudolf Fries Familien-Privatstiftung, a major Austrian industrial investment group. Additionally, Sequestra benefits from multiple federal research and innovation grants from the Austrian The post Austria’s sequestra secures €3 million Seed to scale its CO2 mineralisation technology for industrial use appeared first on EU-Startups.

  • The European Deeptech Week 2026: Startups, speakers and key moments shaping the week (Sponsored)
    on March 18, 2026

    From 16 to 20 March 2026, Paris becomes the meeting point for Europe’s deeptech ecosystem as European Deeptech Week gathers founders, investors, corporates and policymakers for a series of curated discussions and closed-door sessions! While the event is designed around strategic conversations and partnerships, this year’s edition also focuses on the startups and scaleups shaping The post The European Deeptech Week 2026: Startups, speakers and key moments shaping the week (Sponsored) appeared first on EU-Startups.

  • Lausanne-based Rhonexum raises €867.5k to advance cryogenic electronics for scalable quantum computing
    on March 18, 2026

    Rhonexum, a Lausanne-based cryogenic electronics startup, has raised €867.5k ($1 million) in pre-Seed funding to accelerate product development and begin to commercialise its first product, designed to drive the development of scalable quantum computers to initial customers. The round was led by QDNL Participations, with participation from Venture Kick. It has also received non-dilutive funding The post Lausanne-based Rhonexum raises €867.5k to advance cryogenic electronics for scalable quantum computing appeared first on EU-Startups.

  • Barcelona’s Health Lean Analytics bags over €2.1 million to streamline hospital operations with AI and data analytics
    on March 18, 2026

    Health Lean Analytics (HLA), a Barcelona-based startup specialising in automating data collection in hospital environments, has closed a financing round that brings the total capital raised to more than €2.1 million.  The transaction involves a mix of private capital and public funding, with Novanta, a US-listed public company, serving as a technology and strategic partner. The post Barcelona’s Health Lean Analytics bags over €2.1 million to streamline hospital operations with AI and data analytics appeared first on EU-Startups.